18 employees
Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.
2018
$12M
from 2 investors over 2 rounds
Amberstone Biosciences raised $12M on January 3, 2022
Investors: 苏州凯风正德投资管理有限公司 and Viva BioInnovator